S. 3000 · 115th Congress
Patient Advocacy Transparency Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
McCaskillSponsorNo cosponsors.
This bill expands the scope of transparency reports submitted by manufacturers of covered drugs, devices, and medical supplies under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
What it does: CRS summary · Introduced in Senate · Jun 6, 2018
Patient Advocacy Transparency Act
This bill expands the scope of transparency reports submitted by manufacturers of covered drugs, devices, and medical supplies under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Patient Advocacy Transparency Act
Latest action (Jun 6, 2018): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Jun 6, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.